Hsbc Holdings PLC reduced its stake in Maximus, Inc. (NYSE:MMS – Free Report) by 68.7% during the 1st quarter, Holdings Channel reports. The fund owned 4,351 shares of the health services provider’s stock after selling 9,535 shares during the period. Hsbc Holdings PLC’s holdings in Maximus were worth $279,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also recently bought and sold shares of MMS. Seizert Capital Partners LLC acquired a new position in shares of Maximus in the fourth quarter valued at approximately $1,863,000. Ruffer LLP acquired a new stake in Maximus during the 4th quarter worth approximately $6,951,000. UBS Group AG lifted its holdings in Maximus by 76.8% during the 4th quarter. UBS Group AG now owns 610,354 shares of the health services provider’s stock worth $52,686,000 after purchasing an additional 265,095 shares during the last quarter. Comerica Bank boosted its stake in Maximus by 124.4% in the 4th quarter. Comerica Bank now owns 61,284 shares of the health services provider’s stock valued at $5,290,000 after purchasing an additional 33,973 shares during the period. Finally, Intech Investment Management LLC boosted its stake in Maximus by 18.6% in the 4th quarter. Intech Investment Management LLC now owns 61,956 shares of the health services provider’s stock valued at $5,348,000 after purchasing an additional 9,720 shares during the period. 97.21% of the stock is currently owned by institutional investors and hedge funds.
Maximus Stock Up 0.0%
NYSE MMS opened at $60.27 on Monday. The company has a current ratio of 2.21, a quick ratio of 2.21 and a debt-to-equity ratio of 0.87. The company has a market cap of $3.17 billion, a price-to-earnings ratio of 9.02 and a beta of 0.59. The company has a 50 day moving average of $58.68 and a 200-day moving average of $68.52. Maximus, Inc. has a 1-year low of $52.73 and a 1-year high of $100.00.
Maximus Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Friday, August 14th will be issued a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Friday, August 14th. Maximus’s dividend payout ratio is 19.76%.
Wall Street Analysts Forecast Growth
MMS has been the topic of several recent research reports. Weiss Ratings cut Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Wall Street Zen raised shares of Maximus from a “hold” rating to a “buy” rating in a research report on Saturday, June 6th. Finally, Zacks Research downgraded shares of Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 27th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company has an average rating of “Hold”.
View Our Latest Research Report on MMS
Maximus Company Profile
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
See Also
- Five stocks we like better than Maximus
- 3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income Story
- AbbVie Quietly Solved Its Biggest Problem—Now What?
- Rio Tinto’s Results Make the Case for Looking Beyond Tech in the AI Trade
- Strategy’s Structural Strength: Hidden in a $8 Billion Illusion
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
